Clinical Trial Update: Study Evaluating PAZ-417 in Healthy Young/Elderly

View source ↗

Summary

A clinical trial evaluating PAZ-417 in healthy young and elderly participants has completed, with Alzheimer's disease listed as the condition studied.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• PAZ-417

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Alzheimer Disease | Status: COMPLETED